Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
12 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
Energia Pharma Services from Turnhout, company number BE0687743460, closed financial year 2025 with a result of € 434,031 after tax. For that financial year Energia Pharma Services recorded revenue of € 38.3 million and equity of € 5.1 million. Compared with financial year 2024, the result moved from € -114,517 to € 434,031. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 23, 2026.
€ 5.1 million
▲ 9% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 434,031
▲ still € 114,517 loss in 2024
Profit after tax over the fiscal year.
€ 82,713
▼ 80% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 1 million.
People and assets in 2025
16.4
▼ 1 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 1.3 million
▲ 4% vs 2024
€ 81,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 193,298
▼ 14% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 6.1 million
▼ 18% vs 2024
€ 252,647 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.
€ 13.3 million
▲ 12% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 128 days on average.
€ 250,477
▼ 2% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 36,367,981 | € 39,077,889 | € 33,504,328 | € 38,328,485 | ▲ 14% |
| Profit after taxes | € 442,458 | € 171,137 | € -114,517 | € 434,031 | ▲ € 548,548 |
| Equity | € 4,612,220 | € 4,783,358 | € 4,668,841 | € 5,102,872 | ▲ 9% |
| Total debts | € 18,803,968 | € 18,697,059 | € 19,686,233 | € 19,726,696 | |
| Cash | € 944,422 | € 666 | € 411,307 | € 82,713 | ▼ 80% |
| Retained profit | € 550,720 | € 721,858 | € 607,341 | € 1,041,372 | ▲ 71% |
| Bank debt | € 5,967,477 | € 7,072,408 | € 7,504,074 | € 6,139,731 | ▼ 18% |
| Balance sheet total | € 23,416,188 | € 23,480,417 | € 24,355,074 | € 24,829,568 | ▲ 2% |
| Employees (FTE) | 16.8 | 17.7 | 17.4 | 16.4 | ▼ 1 |
Key figures of Energia Pharma Services, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Energia Pharma Services?
What happened at Energia Pharma Services in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Vandecruys Management stepped down as director. NBB
- Blue Eagle Invest NV stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 434,031. Source: NBB ↗
- Vandecruys Management became a director. NBB
- Blue Eagle Invest NV became a director. NBB
- New establishment in Turnhout. KBO
- Start of the company according to the CBE. KBO
In short
From € 442,458 profit in 2022 to € 434,031 profit in 2025.
Paid € 405,275 in corporate taxes since 2022.
Best year ever: 2022, with € 442,458 profit.
Pays suppliers within 128 days on average.
A new publication or filing at Energia Pharma Services? We notify you, reason included.
Follow Energia Pharma ServicesDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The shares are held by Blue Eagle Invest NV. It owns Energia Promotion GmbH and Energia Distribution Afrique itself.
Directors
According to the 2025 annual accounts
since 2021 · until 2027
Managing director · represented by Bruno Jansen
since 2021 · until 2027
Shareholders
Participations
Energia Promotion GmbH
Energia Distribution Afrique
Establishments
Establishment units
Physical locations of this company
Slachthuisstraat 30 box 7
2300 Turnhout
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 12 companies are registered at this address.
All companies at this address →Turnhoutse Vee- en Vleeshandel
B.C.T.
€ 74,310 gross margin · 2025
RUBEC PRODUCTS
€ 143,330 gross margin · 2025
Q GIFTS & CONSULT
€ -4,316 gross margin · 2025
D & G COSMETICS
€ 29,157 gross margin · 2025
+7 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0687.743.460
- VAT number
- BE 0687.743.460
- Registered office
- Slachthuisstraat 30 bus 7, 2300 Turnhout
- Names & denominations
- Energia Pharma Services
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 10 January 2018
- Peppol
- Active · Active since 27 Nov 2025
- Activities · NACE
Markt- en opinieonderzoek
Groothandel in farmaceutische en medische artikelen
Overige detailhandel in voedingsmiddelen, neg
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Activiteiten van reclamebureaus
Overige detailhandel in voedingsmiddelen in gespecialiseerde winkels, n.e.g.
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels